Literature DB >> 19404994

Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS).

Angela G Brega1, Ann Reynolds, Rachael E Bennett, Maureen A Leehey, Lanee S Bounds, Jennifer B Cogswell, Randi J Hagerman, Paul J Hagerman, Jim Grigsby.   

Abstract

BACKGROUND: Fragile X-associated tremor/ataxia syndrome (FXTAS), which occurs in some premutation carriers of the fragile X mental retardation 1 (FMR1) gene, is a neurodegenerative disorder characterized by action tremor, gait ataxia, and impaired executive cognitive functioning.
OBJECTIVE: To evaluate the nature and severity of functional limitations among male carriers of the fragile X premutation, both with and without FXTAS.
METHODS: Forty-two subjects with FXTAS and 24 asymptomatic premutation carriers were compared to 32 control subjects on measures of physical functioning, activities of daily living (ADLs; e.g. eating, bathing), and instrumental activities of daily living (IADLs; e.g. shopping, managing medications). Ordinary least squares regression, controlling for age, education, medical comorbidity, and pain, was used to examine group differences in physical and functional performance.
RESULTS: Men with FXTAS performed significantly worse than control subjects on all dependent measures, showing greater limitations in physical functioning, as well as ADL and IADL performance (p < 0.05). Subsequent analyses suggested that physical and functional impairments among men with FXTAS result largely from deficits in motor and executive functioning and that CGG repeat length is associated with functional impairment. Asymptomatic carriers of the fragile X premutation performed similarly to control subjects on all measures.
CONCLUSIONS: This study provides the first comprehensive evaluation of functional status among male premutation carriers. Although carriers without FXTAS performed similarly to control subjects, men with FXTAS showed evidence of significant physical and functional impairment, which appears to result largely from motor and executive deficits characteristic of the syndrome. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19404994      PMCID: PMC4414034          DOI: 10.1002/gps.2231

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  26 in total

1.  Methods and prevalence of ADL limitations in Hispanic and non-Hispanic white subjects in rural Colorado: the San Luis Valley Health and Aging Study.

Authors:  R F Hamman; C L Mulgrew; J Baxter; S M Shetterly; C Swenson; N E Morgenstern
Journal:  Ann Epidemiol       Date:  1999-05       Impact factor: 3.797

2.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

3.  Confirmatory factor analysis of the behavioral dyscontrol scale in a mixed clinical sample.

Authors:  Eric Ecklund-Johnson; Steven A Miller; Jerry J Sweet
Journal:  Clin Neuropsychol       Date:  2004-08       Impact factor: 3.535

4.  The Purdue pegboard; norms and studies of reliability and validity.

Authors:  J TIFFIN; E J ASHER
Journal:  J Appl Psychol       Date:  1948-06

5.  Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond.

Authors:  D Z Loesch; A Churchyard; P Brotchie; M Marot; F Tassone
Journal:  Clin Genet       Date:  2005-05       Impact factor: 4.438

6.  Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study.

Authors:  J Grigsby; K Kaye; J Baxter; S M Shetterly; R F Hamman
Journal:  J Am Geriatr Soc       Date:  1998-05       Impact factor: 5.562

7.  Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Jim Grigsby; Angela G Brega; Sébastien Jacquemont; Danuta Z Loesch; Maureen A Leehey; Glenn K Goodrich; Randi J Hagerman; Jennifer Epstein; Rebecca Wilson; Jennifer B Cogswell; Tristan Jardini; Flora Tassone; Paul J Hagerman
Journal:  J Neurol Sci       Date:  2006-06-15       Impact factor: 3.181

8.  Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome.

Authors:  Jim Grigsby; Angela G Brega; Karen Engle; Maureen A Leehey; Randi J Hagerman; Flora Tassone; David Hessl; Paul J Hagerman; Jennifer B Cogswell; Rachael E Bennett; Kylee Cook; Deborah A Hall; Lanee S Bounds; Marsha J Paulich; Ann Reynolds
Journal:  Neuropsychology       Date:  2008-01       Impact factor: 3.295

Review 9.  Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.

Authors:  Elizabeth Berry-Kravis; Liane Abrams; Sarah M Coffey; Deborah A Hall; Claudia Greco; Louise W Gane; Jim Grigsby; James A Bourgeois; Brenda Finucane; Sebastien Jacquemont; James A Brunberg; Lin Zhang; Janet Lin; Flora Tassone; Paul J Hagerman; Randi J Hagerman; Maureen A Leehey
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

10.  Activities of daily living in frontotemporal dementia and Alzheimer disease.

Authors:  E Mioshi; C M Kipps; K Dawson; J Mitchell; A Graham; J R Hodges
Journal:  Neurology       Date:  2007-06-12       Impact factor: 9.910

View more
  14 in total

1.  Fragile X mental retardation protein (FMRP) and the spinal sensory system.

Authors:  Theodore J Price; Ohannes K Melemedjian
Journal:  Results Probl Cell Differ       Date:  2012

Review 2.  The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology.

Authors:  Jim Grigsby
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

3.  Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Andreea L Seritan; Kyoungmi Kim; Ian Benjamin; Ioana Seritan; Randi J Hagerman
Journal:  J Geriatr Psychiatry Neurol       Date:  2016-09-21       Impact factor: 2.680

4.  COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Authors:  Andreea Seritan; Jennifer Cogswell; Jim Grigsby
Journal:  Curr Psychiatry Rev       Date:  2013-02

Review 5.  Self-injurious behaviour in intellectual disability syndromes: evidence for aberrant pain signalling as a contributing factor.

Authors:  K A Peebles; T J Price
Journal:  J Intellect Disabil Res       Date:  2011-09-15

Review 6.  Genetic variations underlying self-reported physical functioning: a review.

Authors:  Melissa S Y Thong; Mirjam A G Sprangers; Jeff A Sloan; Donald L Patrick; Ping Yang; Cornelis J F van Noorden
Journal:  Qual Life Res       Date:  2014-11-12       Impact factor: 4.147

7.  Differential increases of specific FMR1 mRNA isoforms in premutation carriers.

Authors:  Dalyir I Pretto; John S Eid; Carolyn M Yrigollen; Hiu-Tung Tang; Erick W Loomis; Chris Raske; Blythe Durbin-Johnson; Paul J Hagerman; Flora Tassone
Journal:  J Med Genet       Date:  2014-10-30       Impact factor: 6.318

Review 8.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

9.  Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Andreea L Seritan; Danh V Nguyen; Yi Mu; Flora Tassone; James A Bourgeois; Andrea Schneider; Jennifer B Cogswell; Kylee R Cook; Maureen A Leehey; Jim Grigsby; John M Olichney; Patrick E Adams; Wendi Legg; Lin Zhang; Paul J Hagerman; Randi J Hagerman
Journal:  J Clin Psychiatry       Date:  2014-03       Impact factor: 4.384

Review 10.  Understanding the neuropsychiatric phenotype of fragile X-associated tremor ataxia syndrome: a systematic review.

Authors:  R C Birch; K M Cornish; D R Hocking; J N Trollor
Journal:  Neuropsychol Rev       Date:  2014-05-15       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.